Six stages of engagement in treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) have been reported by researchers at Boston Medical Center based on a diverse study, inclusive of parents of predominantly racial and ethnic minority children with ADHD. Published in Pediatrics, this…
Read More
Combination therapy improves outcomes for relapsed chronic lymphocytic leukemia
Shuo Ma, MD, '00 PhD, associate professor of Medicine in the Division of Hematology and Oncology, was co-first author of the clinical trial published in Blood. A combination therapy pairing a small molecule inhibitor with monoclonal antibody immunotherapy improved patient…
Read More
Protein markers in chronic lymphocytic leukemia may help determine patients' prognoses
Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. New research published in the Journal of Leukocyte Biology reveals that certain protein markers may indicate which patients have stable forms of CLL and which have more…
Read More
Endocrine Society praises U.S. Supreme Court's decision to uphold the ACA
The Endocrine Society today praised the U.S. Supreme Court's decision to uphold the Affordable Care Act, which makes health care accessible to millions of individuals nationwide, including those with hormone health conditions such as diabetes, osteoporosis, thyroid conditions, and breast…
Read More
IL-6 Levels Tied to Progression of Diabetic Kidney Disease
Higher levels of interleukin-6 (IL-6) are associated with faster progression of proteinuric diabetic kidney disease, new research shows. In addition, higher IL-6 levels are not affected by drugs that block the renin–angiotensin–aldosterone (RAAS) system, which are widely used to treat…
Read More
Addressing climate change for better kidney health
Health has always been affected by climate and weather, but is increasingly clear that the change in climate is a significant threat to human health. The World Health Organization (WHO) estimates that 24% of global deaths are linked to environmental…
Read More
Study reveals prevalence of multimorbidity among people using methamphetamine
People who use methamphetamine are more likely to have health conditions, mental illness, and substance use disorders than people who do not use the drug, according to a new study by researchers at the Center for Drug Use and HIV/HCV…
Read More
Trial results show upadacitinib to be the most effective treatment for atopic dermatitis
The findings of a clinical trial by Trinity College Dublin researchers of treatment for atopic dermatitis have been published today in The Lancet journal (Friday, 21st May, 2021). Results of the clinical trial at the School of Medicine, Trinity College…
Read More
Chronic adverse effects from anti-PD-1 immunotherapies common
(HealthDay)—Chronic immune-related adverse effects after adjuvant treatment with anti-programmed cell death 1 (anti-PD-1) immunotherapies for melanoma are more common than previously thought, according to a study published online March 25 in JAMA Oncology. J. Randall Patrinely Jr., from Vanderbilt University…
Read More
New approach can help identify patients at risk for esophageal cancer
A combination of esophageal brushing and extensive genetic sequencing of the sample collected can detect chromosome alterations in people with Barrett's Esophagus, identifying patients at risk for progressing to esophageal cancer, according to a new study by researchers at the…
Read More